The Ministry of Chemicals and Fertilizers, through the Department of Pharmaceuticals, released an addendum on 4th November 2025. The National Pharmaceutical Pricing Authority (NPPA) updated its earlier orders related to the ceiling price fixation of scheduled IV fluid formulations with special features. This new order adds five manufacturers and marketers to Table B under the existing NPPA order.
The new entries include IV Tech Healthcare, Safal Lifescience Pvt. Ltd., One Drip Healthcare Pvt. Ltd., Life Infusion Pharmaceuticals Pvt. Ltd., Virchow Biotech Pvt. Ltd., Klokter Life Sciences Pvt. Ltd., and Zee Laboratories Ltd. Each company has been assigned specific applicable formulations from Table A, defining which IV fluid variants fall under NPPA’s controlled pricing. Clauses (h5) to (h8) specify these details, ensuring that only certain formulations are subject to the notified ceiling prices.
For instance, IV Tech Healthcare and Life Infusion Pharmaceuticals can apply ceiling prices only for formulations at serial numbers 1, 2, 3, 4, 5, 7, and 8. Similarly, Virchow Biotech, Safal Lifescience, and Klokter Life Sciences have defined applicable formulations based on their product categories. This NPPA update ensures uniform pricing and transparency across the pharmaceutical market, preventing overpricing of essential IV fluids and promoting fair access to life-saving medicines in India.